SCHEMBL13820571

SCHEMBL13820571

c1ccc(-c2c(-c3cccc4ccccc34)c3ccccc3c3cc4c(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)c5ccccc5c(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)c4cc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ATM Q13315 2/20 0.41
KMT2A Q03164 2/20 0.36
MAPT P10636 3/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32
TUBB2A Q13885 1/20 0.32
TUBB8 Q3ZCM7 1/20 0.32
TUBA3E Q6PEY2 1/20 0.32
TUBA1A Q71U36 1/20 0.32
TUBA1C Q9BQE3 1/20 0.32
TUBB6 Q9BUF5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24663119 0.89 L3MBTL1 (0.49) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL22155132 0.87 KDM4E (0.42) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL20022139 0.87 KDM4E (0.46) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL13820524 0.87 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL26813078 0.87 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL18272703 0.86 L3MBTL1 (0.43) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL25658194 0.86 KDM4E (0.43) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL22706374 0.84 KDM4E (0.46) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL12571775 0.84 KDM4E (0.41) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL16657313 0.84 KDM4E (0.41) L3MBTL1KDM4EATMKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2012-11-15 US disclosed
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2012-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, LEF1, OR51E2 L3MBTL1 414/4885KDM4E 1591/4885ATM 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.